Brief: SANUWAVE Health provides an update on the dermapace clinical trial
30/06/2015 13:00
June 30 (Reuters) - SANUWAVE Health Inc SNWV.PK : * Provides an update on the dermapace clinical trial * Source text for Eikon ID:nGNXVDXBOa * Further company coverage SNWV.PK ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on SANUWAVE Health
See all newsSANUWAVE Health Q2 revenue falls, withdraws FY guidance amid Medicare reimbursement uncertainty
Brief: Sanuwave Health Updates Second Quarter 2026 Guidance
Brief: Sanuwave Health - Forecasts Q2 2026 Revenue $11.1-$11.6 Million, Fy2026 Revenue $51.0-$55.0 Million - SEC Filing
SANUWAVE Health Q1 swings to operating loss as margins fall
Brief: Sanuwave Health Reports Preliminary Q1 2026 Revenue Of $9.6–$9.7 Million, Up 3-4% Year-Over-Year